Terms: = Leukemia AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Prognosis
524 results:
1. Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.
Hu Z; Yang Y; Li J; Hu Z
Hematology; 2024 Dec; 29(1):2346965. PubMed ID: 38687637
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical Characteristics and prognosis of Acute Myeloid leukemia Patients with
Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Molecular Profiling of npm1-Mutated Acute Myeloid leukemia Using RNAseq Approach.
Petiti J; Pignochino Y; Schiavon A; Giugliano E; Berrino E; Giordano G; Itri F; Dragani M; Cilloni D; Lo Iacono M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612443
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].
Hao MZ; Zhao XL; Zhang XY; Shi YY; Gong M; Zhang LN; Chen SL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):995-1000. PubMed ID: 38503522
[No Abstract] [Full Text] [Related]
6. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
Zhang WW; Zhang YL; Ren CC; Wu TK; Liu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):176-183. PubMed ID: 38387918
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
[TBL] [Abstract] [Full Text] [Related]
8. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.
Wang LY; Li Y; Jiang Q; Jiang H; Wang Y; Xu LP; Zhang XH; Liu KY; Tang FF
Hematol Oncol; 2024 Mar; 42(2):e3256. PubMed ID: 38367260
[TBL] [Abstract] [Full Text] [Related]
10. Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid leukemia.
Shen J; Wen X; Xing X; Fozza C; Sechi LA
Front Cell Infect Microbiol; 2023; 13():1339673. PubMed ID: 38274728
[TBL] [Abstract] [Full Text] [Related]
11. Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk npm1-mutated AML.
Chan O; Al Ali N; Tashkandi H; Ellis A; Ball S; Grenet J; Hana C; Deutsch Y; Zhang L; Hussaini M; Song J; Yun S; Talati C; Kuykendall A; Padron E; Walker A; Roboz G; Desai P; Sallman D; Sweet K; Komrokji R; Lancet J
Blood Adv; 2024 Mar; 8(5):1075-1083. PubMed ID: 38170740
[TBL] [Abstract] [Full Text] [Related]
12. The ferroptosis landscape in acute myeloid leukemia.
Ma Z; Ye W; Huang X; Li X; Li F; Lin X; Hu C; Wang J; Jin J; Zhu B; Huang J
Aging (Albany NY); 2023 Nov; 15(22):13486-13503. PubMed ID: 38032290
[TBL] [Abstract] [Full Text] [Related]
13. Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.
Yu T; Zhan Q; Yan X; Luo X; Wang X; Tang X; Zhang H; Yang Z; Chen J; Liu L; Wang L
Cancer Biol Ther; 2023 Dec; 24(1):2285801. PubMed ID: 38031921
[TBL] [Abstract] [Full Text] [Related]
14. Detection of npm1 Mutations in Acute Myeloid leukemia by using Drop-Off Droplet Digital PCR and its Clinical Application.
Jin Y; Xu ZJ; Yu D; Xia PH; Yao DM; Yuan Q; Li T; Xiang HL; Ma JC; Wen XM; Lin J; Qian J
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948486
[TBL] [Abstract] [Full Text] [Related]
15. MLPA in the initial genetic screening of patients with acute myeloid leukemia.
Yahya D; Hachmeriyan M; Ruseva T; Chervenkov T; Micheva I
Rom J Intern Med; 2024 Mar; 62(1):44-51. PubMed ID: 37948316
[TBL] [Abstract] [Full Text] [Related]
16. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
[TBL] [Abstract] [Full Text] [Related]
17. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with npm1 and FLT3 mutations.
Han S; Patel T; Garcia ML; Tirado M
J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
[TBL] [Abstract] [Full Text] [Related]
18. Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia.
Huang W; Zheng S; Wang Q; Zhao N; Long Z
Sci Rep; 2023 Sep; 13(1):15658. PubMed ID: 37730831
[TBL] [Abstract] [Full Text] [Related]
19. [Characteristics of genetic variants in 134 patients with Acute myeloid leukemia].
He M; Zhao X; Tian H; Zhang S; Zhao F; Zhang X; Wu T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Oct; 40(10):1222-1227. PubMed ID: 37730221
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact of FLT3-ITD mutation on npm1
Pan X; Chang Y; Ruan G; Wei F; Jiang H; Jiang Q; Huang X; Zhao X
Br J Haematol; 2023 Oct; 203(2):212-223. PubMed ID: 37621257
[TBL] [Abstract] [Full Text] [Related]
[Next]